Literature DB >> 17056286

Hybrid-procedures for the treatment of thoracoabdominal aortic aneurysms and dissections.

M Gawenda1, M Aleksic, J Heckenkamp, V Reichert, A Gossmann, J Brunkwall.   

Abstract

AIM: The conventional open repair of thoracoabdominal aneurysms and dissections remains complex and demanding and is associated with significant morbidity and mortality. We present our experience of hybrid open and endovascular treatment of thoracoabdominal aneurysms and dissections.
METHODS: Within an experience of 226 aortic stent-grafts between 1998 and April 2006, 6 of the patients (median age 60 years, range 35 to 68 years) with thoracoabdominal aneurysms (Crawford type I, II, III, and V) were treated with a combined endovascular and open surgical approach. Five men and one woman, with median aneurysm diameter of 75 mm (range 70-100 mm), received revascularization of the renal arteries, the superior mesenteric artery, and the coeliac trunk accomplished via transperitoneal bypass grafting. Aneurysmal exclusion was then performed by stent-graft deployment.
RESULTS: The entire procedure was technically successful in all patients. The patients were discharged a median of 9 days after the operation, while the postoperative studies revealed the patency of the vessels and no evidence of type I endoleak or secondary rupture of the aneurysm. During follow up (1 to 22 months) spiral-CT scanning revealed distinct shrinkage of the aneurysm, no graft migration or endoleak and patency of all revascularised vessels, except one renal artery in two patients. No patient experienced any temporary or permanent neurological deficit, and no dialysis was necessary.
CONCLUSION: The combined endovascular and open surgical approach is feasible, without cross clamping of the aorta and with minimized ischemia time for renal and visceral arteries, and seems to be an appropriate strategy for patients with a thoraco-abdominal aortic aneurysm or dissection.

Entities:  

Mesh:

Year:  2006        PMID: 17056286     DOI: 10.1016/j.ejvs.2006.09.002

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  6 in total

Review 1.  Debranching aortic surgery.

Authors:  Manuel Alonso Pérez; José Manuel Llaneza Coto; José Antonio Del Castro Madrazo; Carlota Fernández Prendes; Mario González Gay; Amer Zanabili Al-Sibbai
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

2.  Hybrid treatment of a thoracoabdominal aortic aneurysm in China: report of the first successful case.

Authors:  Bin Huang; Ding Yuan; Jichun Zhao; Yukui Ma
Journal:  Surg Today       Date:  2012-04-03       Impact factor: 2.549

3.  Initial experience in the treatment of thoracic aortic aneurysmal disease with a thoracic aortic endograft at Baylor University Medical Center.

Authors:  Jeffrey Apple; Karen L McQuade; Baron L Hamman; Robert F Hebeler; William P Shutze; Dennis R Gable
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-04

4.  Balloon-assisted coil embolization of the celiac trunk before endovascular aortic repair of thoracoabdominal aortic aneurysm.

Authors:  Masayuki Endo; Toshio Kaminou; Yasufumi Ohuchi; Kimihiko Sugiura; Shinsaku Yata; Akira Adachi; Tsuyoshi Kawai; Syohei Takasugi; Shuichi Yamamoto; Kensuke Matsumoto; Masayuki Hashimoto; Takashi Ihaya; Toshihide Ogawa
Journal:  Jpn J Radiol       Date:  2013-01-12       Impact factor: 2.374

5.  Hybrid-repair of thoraco-abdominal or juxtarenal aortic aneurysm: what the radiologist should know.

Authors:  Tobias Krauss; Thomas Pfammatter; Dieter Mayer; Mario Lachat; Lukas Hechelhammer; Borut Marincek; Thomas Frauenfelder
Journal:  Eur Radiol       Date:  2009-09-30       Impact factor: 5.315

6.  Treatment of a rapidly expanding thoracoabdominal aortic aneurysm after endovascular repair of descending thoracic aortic aneurysm in an old patient.

Authors:  Vito Mannacio; Michele Mottola; Danilo Ruggiero; Andrea D'Alessio; Giuseppina Gabriella Surace; Ettorino Di Tommaso; Bruno Amato; Gabriele Iannelli
Journal:  BMC Surg       Date:  2012-11-15       Impact factor: 2.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.